Xcout IntelMammoth Biosciences
Mammoth Biosciences is a biotechnology company based in Brisbane, California developing diagnostic tests using CRISPR-Cas12a and CRISPR-based therapies using its proprietary ultra-small CRISPR systems. Several CRISPR-Cas systems identified through the company's metagenomics-based protein discovery platform, including members of the Casφ and Cas14 families of CRISPR-associated enzymes, have demonstrated potential for therapeutic genome editing in in vivo settings.
Subscribe to see Mammoth Biosciences’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Mammoth Biosciences at a glance
Mammoth Biosciences is a biotechnology company headquartered in United States, founded in 2017. It has raised at least $65.6M across the 3 funding rounds on record. Its most recent funding round raised $45M in January 2020. Xcout recorded 5 job postings from Mammoth Biosciences in the last 90 days.
Mammoth Biosciences funding rounds
At least $65.6M raised across the 3 rounds on record. Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| — | $45M | 1 named | |
| SEC Form D filing | $7.4M | — | |
| SEC Form D filing | $13.2M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at Mammoth Biosciences
Xcout recorded 5 job postings from Mammoth Biosciences in the last 90 days, from a hiring record Xcout has kept since July 2026.
The weekly hiring trend, the roles and locations behind it — see Mammoth Biosciences's hiring signals →
Investors
Mammoth Biosciences competitors
A few of Mammoth Biosciences's closest competitors — see the full list of competitors and alternatives →
23andMe, Inc. is a leading consumer genetics and research company that helps people access, understand, and benefit from their genetic information. It offers DNA testing services for ancestry and health, and utilizes its crowdsourced genetic research platform for drug discovery programs across various disease areas.
Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developing therapeutic solutions for patients. The company utilizes a distinctive genome editing toolkit, sourced from metagenomics, for its development efforts within the United States. This advanced toolkit comprises programmable nucleases, base editors, and sophisticated RNA and DNA-mediated integration systems, notably prime editing and CRISPR-associated transposases. Metagenomi has established several key collaborations: a strategic alliance with ModernaTX, Inc. to explore new genome editing systems for in vivo human therapeutic applications; a development and licensing agreement with Affini-T Therapeutics, Inc. to create and commercialize gene-edited T-cell receptor therapies for human cancer; and a partnership with Ionis Pharmaceuticals, Inc. to research, develop, and market investigational medicines leveraging genome editing technologies. Founded in 2016, the company is based in Emeryville, California.
Excision BioTherapeutics Inc. is a San Francisco-based clinical-stage biotechnology company focused on developing advanced gene editing therapeutics to treat infectious diseases.
Colossal Biosciences is a biotechnology and genetic science company headquartered in Dallas, Texas, specializing in de-extinction initiatives and advanced genomics research.
BreezeBio is a biotechnology company headquartered in the South San Francisco area of California that develops precision genetic medicines.
Synthorx, Inc., founded in 2014, is a biotechnology company headquartered in La Jolla, California, that engineered expanded genetic alphabet technologies to discover and develop novel protein therapeutics.
Get Mammoth Biosciences's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Mammoth Biosciences in Xcout Intel
- 3 funding rounds with the investors in each, and who they co-invest with
- Weekly hiring history and the mix of roles behind it
- The full competitor set, tracking, exports and API access